rs61295588
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM1PM2PP2PP3_StrongPP5_Very_Strong
The NM_170707.4(LMNA):c.644T>C(p.Leu215Pro) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L215V) has been classified as Uncertain significance.
Frequency
Consequence
NM_170707.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMNA | NM_170707.4 | c.644T>C | p.Leu215Pro | missense_variant | Exon 4 of 12 | ENST00000368300.9 | NP_733821.1 | |
LMNA | NM_005572.4 | c.644T>C | p.Leu215Pro | missense_variant | Exon 4 of 10 | ENST00000677389.1 | NP_005563.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMNA | ENST00000368300.9 | c.644T>C | p.Leu215Pro | missense_variant | Exon 4 of 12 | 1 | NM_170707.4 | ENSP00000357283.4 | ||
LMNA | ENST00000677389.1 | c.644T>C | p.Leu215Pro | missense_variant | Exon 4 of 10 | NM_005572.4 | ENSP00000503633.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 2 Pathogenic:1
This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 215 of the LMNA protein (p.Leu215Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with conduction disease and/or dilated cardiomyopathy (PMID: 12486434). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 65764). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LMNA protein function. Experimental studies have shown that this missense change affects LMNA function (PMID: 20160190). For these reasons, this variant has been classified as Pathogenic. -
Cardiovascular phenotype Pathogenic:1
The p.L215P variant (also known as c.644T>C), located in coding exon 4 of the LMNA gene, results from a T to C substitution at nucleotide position 644. The leucine at codon 215 is replaced by proline, an amino acid with similar properties. This alteration has been detected in a family with cardiac conduction defects and dilated cardiomyopathy (DCM), showing segregation within the family (Hershberger RE et al. Am Heart J, 2002 Dec;144:1081-6). Based on internal structural analysis, this variant is anticipated to result in a significant decrease in structural stability (Bunick CG et al. J Invest Dermatol, 2017 01;137:142-150). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
not provided Other:1
- -
Dilated cardiomyopathy 1A Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at